[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: standard care and amphotericin B: Standard of care+ Intervention- Intranasal amphotericin B preparation; Patient advised to instil dilute amphotericin nasal drops into both nostrils 3 times/ day for 14 days from day of randomization. Standard of care: All patients affected with COVID-19 illness are classified and treated according to hospital protocol derived from NIH guidelines; CDC guidelines; NICE guidelines; American Society of Haematology guidelines. The co morbidities especially hyperglycaemia is treated according to hospital guidelines given by department of General Medicine.Control Intervention1: standard of care and placebo: placebo- Saline nasal drops; Patient will be advised to instil saline nasal drops into both nostrils three times a day for 14 days from the day of randomization", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: standard care and amphotericin B: Standard of care+ Intervention- Intranasal amphotericin B preparation; Patient advised to instil dilute amphotericin nasal drops into both nostrils 3 times/ day for 14 days from day of randomization. Standard of care: All patients affected with COVID-19 illness are classified and treated according to hospital protocol derived from NIH guidelines; CDC guidelines; NICE guidelines; American Society of Haematology guidelines. The co morbidities especially hyperglycaemia is treated according to hospital guidelines given by department of General Medicine.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: standard of care and placebo: placebo- Saline nasal drops; Patient will be advised to instil saline nasal drops into both nostrils three times a day for 14 days from the day of randomization", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 1886, "treatment_name": "Amphotericin b", "treatment_type": "Other anti-infectives", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "N/A", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: standard care and amphotericin B: Standard of care+ Intervention- Intranasal amphotericin B preparation; Patient advised to instil dilute amphotericin nasal drops into both nostrils 3 times/ day for 14 days from day of randomization. Standard of care: All patients affected with COVID-19 illness are classified and treated according to hospital protocol derived from NIH guidelines; CDC guidelines; NICE guidelines; American Society of Haematology guidelines. The co morbidities especially hyperglycaemia is treated according to hospital guidelines given by department of General Medicine.Control Intervention1: standard of care and placebo: placebo- Saline nasal drops; Patient will be advised to instil saline nasal drops into both nostrils three times a day for 14 days from the day of randomization", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: standard care and amphotericin B: Standard of care+ Intervention- Intranasal amphotericin B preparation; Patient advised to instil dilute amphotericin nasal drops into both nostrils 3 times/ day for 14 days from day of randomization. Standard of care: All patients affected with COVID-19 illness are classified and treated according to hospital protocol derived from NIH guidelines; CDC guidelines; NICE guidelines; American Society of Haematology guidelines. The co morbidities especially hyperglycaemia is treated according to hospital guidelines given by department of General Medicine.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: standard of care and placebo: placebo- Saline nasal drops; Patient will be advised to instil saline nasal drops into both nostrils three times a day for 14 days from the day of randomization", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}]